ScottLawrenceGottliebMD

Dermatology • Exton, PA

Physician

Join to view full profile

Dr. Gottlieb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gottlieb's full profile

Already have an account?

Office
501 Gordon Dr
Exton, PA 19341
Phone+1 610-594-6660

Fax+1 610-594-6810
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemResidency, Dermatology, 1995 - 1998
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
Weill Cornell MedicineClass of 1990

Certifications & Licensure

NY State Medical License 2002 - 2026
NJ State Medical License 1997 - 2025
PA State Medical License 1994 - 2024
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FAAD) American Academy of Dermatology
Top MD Consumers Checkbook

Clinical Trials

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis Start of enrollment: 2019 Oct 29
Completed
Phase 3
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) Start of enrollment: 2020 Jun 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

7 citations
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.
Joel M Gelfand, Daniel B Shin, April W Armstrong, Stephen K Tyring, Andrew Blauvelt, Scott Gottlieb, Benjamin N Lockshin, Robert E Kalb, Robert Fitzsimmons, Justin Rod...> ;JAMA Dermatology. 2022 Dec 1
56 citations
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).
Joel M. Gelfand, Daniel B. Shin, Kristina Callis Duffin, April W. Armstrong, Andrew Blauvelt, Stephen K. Tyring, Alan Menter, Scott Gottlieb, Benjamin Lockshin, Eric L...> ;The Journal of Investigative Dermatology. 2020 Sep 1
137 citations
The wrinkle severity rating scale: a validation study.
Doris Day, Curt M. Littler, Richard W. Swift, Scott L. Gottlieb> ;American Journal of Clinical Dermatology. 2004 Jan 1
Breast cancer patients can stop tamoxifen after 5 years.
Scott Gottlieb> ;The Western Journal of Medicine. 2001 Jul 1
AMA criticized for calling for condoms in schools.
Scott Gottlieb> ;The Western Journal of Medicine. 2000 Mar 1
4 citations
Right-to-die bills defeated in more than 28 states.
Scott Gottlieb> ;The Western Journal of Medicine. 1999 Oct 1
NCI defends research involving minority groups.
Scott L. Gottlieb> ;Nature Medicine. 1999 Mar 1
2 citations
Beyond HMOs: Understanding the Next Wave of Change in Health-Care Organization
Scott Gottlieb, Thomas A. Einhorn> ;The Journal of the American Academy of Orthopaedic Surgeons. 1998 Mar 1
9 citations
Managed care: form, function, and evolution.
Scott Gottlieb, Thomas A. Einhorn> ;The Journal of Bone and Joint Surgery. American Volume. 1997 Jan 1
147 citations
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a sin...
Scott L. Gottlieb, Jonathan T. Wolfe, Floyd E Fox, Barbara J. DeNardo, William H. Macey, Patricia G. Bromley, Stuart R. Lessin, Alain H. Rook> ;Journal of the American Academy of Dermatology. 1996 Dec 1
16 citations
Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infiltration in psoriatic plaques by topical calcitriol
Irene Lu, Patricia Gilleaudeau, John Arthur Mclane, Noah Heftier, Markus Kamber, Scott L. Gottlieb, James G. Krueger, Alice B. Gottlieb> ;Journal of Cutaneous Pathology. 1996 Oct 1
36 citations
Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell‐mediated inflammation are unexpected outcomes
Scott L. Gottlieb, Elizabeth Hayes, Patricia Gilleaudeau, Irma Cardinale, Alice B. Gottlieb, James G. Krueger> ;Journal of Cutaneous Pathology. 1996 Oct 1
33 citations
Reversal of acute renal allograft rejection by extracorporeal photopheresis: A case presentation and review of the literature
Jonathan T. Wolfe, John E. Tomaszewski, Robert A. Grossman, Scott L. Gottlieb, Ali Naji, Kenneth L. Brayman, Sydney M. Kobrin, Alain H. Rook> ;Journal of Clinical Apheresis. 1996 Jan 1
22 citations
Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: A clinical and pathologic study
Scott L. Gottlieb, Noah S Heftler, Patricia Gilleaudeau, Ray Johnson, Val Pierre Vallat, Jonathan Wolfe, Alice B. Gottlieb, James G. Krueger> ;Journal of the American Academy of Dermatology. 1995 Oct 1
446 citations
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.
Scott L. Gottlieb, Patricia Gilleaudeau, Ray Johnson, Len Estes, Thasia G. Woodworth, Alice B. Gottlieb, James G. Krueger> ;Nature Medicine. 1995 May 1
Join now to see all

Press Mentions

Ross: COVID Vaccine Booster Mixed Messaging Is the Worst Misstep of the PandemicNovember 15th, 2021
With COVID-19 Cases on Rise Again, Pennsylvania Officials Concerned About Thanksgiving SurgeNovember 15th, 2021
The Rate of Covid-19 Cases Is Dropping Nationally but Rising in These 5 StatesOctober 10th, 2021
Join now to see all